Skip to main content
. 2017 Nov 12;7:57–70. doi: 10.1016/j.molmet.2017.10.014

Figure 7.

Figure 7

VPS13C knock down increases targeting of ATGL to LDs. A) Western blot for ATGL in BA cell fractions. Left panel: representative Western blot; right panel: cumulative data (n = 4). KD = BA knocked down for VPS13C; PN = post-nuclear; cyto = cytoplasm; LD = lipid droplets. B) Western blot for phospho-HSL and HSL in total lysates from cells treated with control shRNA (ctrl) or shRNA against VPS13C (KD). Left panel: representative Western blot; right panel cumulative data (n = 4) C) Immunostaining for ATGL in control and VPS13C-silenced BAs.